A case report on Alagille syndrome and its clinical features

Somanaboina Padmakar (1) , Sayed Alishar (2) , Mohammad Ahamadi Tabasum (3)
(1) Research scholar, Department of pharmacology, Lovely Professional University, Phagwara – 144001, Punjab, India, India ,
(2) P. Rami Reddy Memorial College of Pharmacy, Kadapa – 516003, Andhra Pradesh, India, India ,
(3) P. Rami Reddy Memorial College of Pharmacy, Kadapa – 516003, Andhra Pradesh, India, India

Abstract

Alagille syndrome is a rare, chromosome dominant inherited complex disorder affecting varying organs like the liver, heart, kidneys, skeleton, and brain. lt invariably happens because of Notch signaling pathway defects, primarily as a result of JAG1 mutation (ALGS type 1), but it conjointly occurs seldom because of neurogenic locus notch homolog protein (NOTCH2) mutation (ALGS type 2). The symptoms and severity of Alagille syndrome can vary widely, often in the same family, from person to person. Some people may have mild forms, while others may have more severe forms. Blocking of bile flow from the liver (cholestasis), yellowish discoloration of the skin and mucosal membranes (jaundice), low body weight, and extreme itching (pruritis) are the common symptoms, which often occur within the first three months of life. In this current study, we tend to report a case of 14 years old female child who was hospitalized with characteristic facial features like a broad forehead, yellowish discoloration of sclera and skin, posterior embryotoxon, intense itching, dry, coarse skin, mild splenomegaly, mild hepatomegaly. She conjointly had a history of progressive neonatal jaundice with prominent skin lesions and edema. Therefore our study emphasizes and focuses mainly on understanding and identification of distinct features associated with this syndrome to aid better management in all cases.

Full text article

Generated from XML file

References

Ayoub, M. D., Kamath, B. M. 2020. Alagille Syndrome: Diagnostic Challenges and Advances in Management. Diagnostics, 10(11):907.

Chitayat, D., Kamath, B., Saleh, M. 2016. Alagille syndrome: clinical perspectives. The Application of Clinical Genetics, 9:75–82.

Dědič, T., Jirsa, M., Keil, R., Rygl, M., Šnajdauf, J., Kotalová, R. 2015. Alagille Syndrome Mimicking Biliary Atresia in Early Infancy. Plos One, 10(11):1–7.

Elkhoury, J. W., Venetz, J. P., Rutz, T. 2019. Alagille syndrome. Revue Medicale Suisse, 15(660):1506–1510.

Huang, T., Yang, G., Dang, X. 2017. Implementing targeted region capture sequencing for the clinical detection of Alagille syndrome: An efficient and cost-effective method. Molecular Medicine Reports, 16(5):6876–6881.

Kamath, B. M., Loomes, K. M., Piccoli, D. A. 2010. Medical Management of Alagille Syndrome. Journal of Pediatric Gastroenterology and Nutrition, 50(6):580–586.

Ma, Y. L., Song, Y. Z. 2014. Advances in the diagnosis and treatment of Alagille syndrome. Chinese Journal of Contemporary Pediatrics, 16(11):1188–1192.

Singh, S. P., Pati, G. K. 2018. Alagille Syndrome and the Liver: Current Insights. Euroasian Journal of Hepato-Gastroenterology, 8(2):140–147.

Turnpenny, P. D., Ellard, S. 2012. Alagille syndrome: pathogenesis, diagnosis and management. European Journal of Human Genetics, 20(3):251–257.

Authors

Somanaboina Padmakar
spadmakar717@gmail.com (Primary Contact)
Sayed Alishar
Mohammad Ahamadi Tabasum
Somanaboina Padmakar, Sayed Alishar, & Mohammad Ahamadi Tabasum. (2021). A case report on Alagille syndrome and its clinical features. International Journal of Research in Pharmaceutical Sciences, 12(3), 1818–1821. Retrieved from https://ijrps.com/home/article/view/97

Article Details

No Related Submission Found